Use of DNA molecules substituted with unnatural nucleotides to probe specific drug-DNA interactions.
Bailly
C
C
INSERM U-524, and Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret IRCL, 59045 Lille, France.
Waring
M J
MJ
D044503:5-Methylcytosine; D020029:Base Pairing; D001665:Binding Sites; D003596:Cytosine / Q000031:analogs & derivatives / Q000737:chemistry; D004247:DNA / Q000737:chemistry* / Q000378:metabolism*; D017931:DNA Primers / Q000235:genetics; D015342:DNA Probes / Q000737:chemistry; D003854:Deoxyribonucleotides / Q000737:chemistry*; D007288:Inosine / Q000737:chemistry; D046911:Macromolecular Substances; D015394:Molecular Structure; D009690:Nucleic Acid Conformation; D004364:Pharmaceutical Preparations / Q000737:chemistry* / Q000378:metabolism*; D016133:Polymerase Chain Reaction / Q000379:methods*; D014529:Uridine / Q000737:chemistry
D017931:DNA Primers; D015342:DNA Probes; D003854:Deoxyribonucleotides; D046911:Macromolecular Substances; D004364:Pharmaceutical Preparations; D007288:Inosine; D044503:5-Methylcytosine; D003596:Cytosine; D004247:DNA; D014529:Uridine